about
The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.Sustained release of melatonin: A novel approach in elevating efficacy of tamoxifen in breast cancer treatment.The role of Six1 signaling in paclitaxel-dependent apoptosis in MCF-7 cell line.Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.Amphiphilic block co-polymers: preparation and application in nanodrug and gene delivery.Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.Six family of homeobox genes and related mechanisms in tumorigenesis protocols.Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.CDK9 Regulates Apoptosis of Myoblast Cells by Modulation of microRNA-1 Expression.Development of a Terbium-Sensitized Fluorescence Method for Analysis of Silibinin.STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.Immunomodulatory and anticancer effects of intra-tumoral co-delivery of synthetic lipid A adjuvant and STAT3 inhibitor, JSI-124Clinical application of immune checkpoints in targeted immunotherapy of prostate cancerSTAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cellsPoly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin
P50
Q34517533-91E36D18-80F4-4D2D-ADC3-9E8C2629C6E5Q36006253-7F051577-69B7-4007-9F17-FF1657872D12Q36614217-2BCA5E6E-32B1-44AE-A279-C91170507EF9Q37146723-43EBBDDB-C475-488E-AD56-973EEA5381F4Q37992493-ACC96EAD-6FFA-437B-9B5A-1C28C9450AB8Q38724100-D000FDDC-970E-4634-9B9D-644844F9F6BBQ38801339-DB95EA0B-13AB-4DD8-A3F1-B54F91C4CDC0Q38858006-2055A34E-DBE3-4840-958E-FE86E270AB59Q38996894-4B89639C-961A-4344-AA4D-FAC461106496Q39069248-B2A22884-E463-4A07-9FCD-8CC4659C8EFBQ39994717-3CDF2A8A-427C-4B5B-B22D-F9A65E234F06Q40063196-63C48F93-C095-44B6-B068-D9EF1D8EC5AAQ46143190-FE7B6C2F-A709-4761-AEDD-CD161CA3FA57Q48023556-7B076B2D-ADE0-41E1-988F-1C2CDB5ACE4AQ51171409-51B94B21-E922-4933-ABD7-E4D64C2423FFQ52947650-0CD91134-40CC-498C-AC16-CB311308842CQ81978946-75E027EA-A330-4980-A30D-4754F2870C3DQ89475852-1C5E9E9A-C6D9-429D-A65C-0A6BA0DCCB3DQ92672845-24447A2B-9C2F-450C-B6BB-6574928FC30EQ94503595-F3FE000A-A496-4A43-8470-52402AD4C14C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ommoleila Molavi
@ast
Ommoleila Molavi
@en
Ommoleila Molavi
@es
Ommoleila Molavi
@nl
Ommoleila Molavi
@sl
type
label
Ommoleila Molavi
@ast
Ommoleila Molavi
@en
Ommoleila Molavi
@es
Ommoleila Molavi
@nl
Ommoleila Molavi
@sl
prefLabel
Ommoleila Molavi
@ast
Ommoleila Molavi
@en
Ommoleila Molavi
@es
Ommoleila Molavi
@nl
Ommoleila Molavi
@sl
P106
P1153
14527586600
P31
P496
0000-0002-1820-7048